GSR and Familial prostate cancer: Chakraborty and colleagues found that pterostilbene modified Bcl-2, Bax, and caspase 3, markers of mitochondrial apoptosis, and increased expression of the antioxidant enzymes GPx, GR, and GSH by 1.4-, 1.6-, and 2.1-fold in prostate cancer cells [21].